品牌故事
Increase the Certainty of Drug Development Success
The drug discovery and development process is complex, with more failures than successes. As your trusted partner, we accelerate medicines to patients, using biosimulation (modeling and simulation) and technology-enabled services to transform drug discovery and development.
Our integrated and proprietary end-to-end platform with generative AI technology, biosimulation, regulatory science, and market access solutions combined with our global 1,400+ strong team of scientists and experts enable informed decision-making, higher R&D productivity, and improved patient outcomes. With our quantitative approach, we anticipate and address your critical drug discovery and development decisions:
- 如何优化剂量以最大程度地提高安全性和效率？
- 临床试验取得成功的概率是多少？
- 我们如何与监管机构合作来应对不确定性？
- What’s the best way to assess and demonstrate the maximum value of a new therapy?
Certara 业务范围涉及所有治疗领域和创新疗法，包括免疫肿瘤学、罕见病、中枢神经系统 (CNS)、呼吸疾病、基因疗法和全球健康，从而为从药物发现到患者获得药物的全过程提供转化解决方案。
Certara’s End-to-End Platform
>90%
在过去 9 年里，FDA 批准的药物中超过 90% 是由我们的客户申报的
300+
在过去 5 年中，编写并递送了 200 多项全球监管和卫生当局提交件
60,000+
drug developers are end-users worldwide
我们的历史
2008 年，Tripos International 和 Pharsight Corporation 合并组建了 Certara。Since then, we have achieved incredible growth through acquisitions and the pharmaceutical industry and regulatory agencies’ adoption of model-informed drug development (MIDD).
Today, we are the global leader in biosimulation.
We can help you go farther, faster. Wherever you are in your drug development journey, Certara can help you improve decision-making.
Image Credit: JUSTIN LANE/EPA-EFE/Shutterstock
Unmatched MIDD Expertise at Scale
我们的高质量工作是奉献、协作和深厚专业知识的共同结果。
With Certara, your partners are experts who are committed to finding the right answers and increasing the probability of your success.
我们顶尖的科学家和专家通过零缺陷执行力和管理工作来应对复杂的情况，以助您实现目标。
客户第一
您取得成功即是我们的指导原则。Trusted by more than 2,400 biopharmaceutical companies, academic institutions, and regulatory agencies across 66 countries, we are members of your team.
我们使用定量科学和一体化方法来设计并实施药物开发策略，以
- 更快地进入概念验证
- 优化试验设计
- 减小试验规模或完全避免某些试验
- 加快监管提交
- 扩大患者获得药品的机会
Recognized as an Employer of Choice
We foster a culture of excellence that is reflected in our reputation and achievement. For two years in a row, Certara has been Certified as a Great Place to Work. In fact, 88% of Certara employees say it is a great place to work compared to 57% of employees at a typical U.S.-based company.
Certara 可以为您提供怎样的帮助？
开启与我们的对话吧
